Scholar Rock Holding (SRRK) Other Accumulated Expenses (2017 - 2026)

Scholar Rock Holding's (SRRK) quarterly Other Accumulated Expenses came in at $775000.0 in Q1 2026, up 3.47% year-on-year from $749000.0 in Q1 2025, and down 45.35% quarter-over-quarter from $1.4 million in Q4 2025.

Scholar Rock Holding (SRRK) Other Accumulated Expenses (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Other Accumulated Expenses history runs 10 years deep, the most recent figure standing at $775000.0 for Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses rose 3.47% year-over-year to $775000.0 in Q1 2026; TTM through Mar 2026 was $775000.0, a 3.47% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 61.32% from the prior year.
  • Other Accumulated Expenses declined to $775000.0 in Q1 2026 per SRRK's latest filing, from $1.4 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $1.4 million in Q4 2025 and bottomed at $85000.0 in Q4 2023.
  • The 5-year median for Other Accumulated Expenses is $831000.0 (2024), against an average of $783235.3.
  • Across the five-year window, Other Accumulated Expenses tumbled 89.8% in 2023 and jumped 934.12% in 2024, its largest moves.
  • Year by year, Other Accumulated Expenses stood at $833000.0 in 2022, then plunged by 89.8% to $85000.0 in 2023, then soared by 934.12% to $879000.0 in 2024, then jumped by 61.32% to $1.4 million in 2025, then slumped by 45.35% to $775000.0 in 2026.
  • Per Business Quant, the three latest SRRK Other Accumulated Expenses figures stand at $775000.0 (Q1 2026), $1.4 million (Q4 2025), and $867000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,583.17 Bn 67,582.89 Bn -
2 Nanobiotix 1,947.22 Bn 1,947.15 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 473.21 Bn 468.42 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.29 Bn 116.04 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.05 Bn 61.29 Bn 3.31 Bn
7 Belite Bio 63.09 Bn 63.09 Bn -
8 Argenx Se 56.63 Bn 51.45 Bn 1.41 Bn
9 Revolution Medicines 37.79 Bn 37.79 Bn -
10 Scholar Rock Holding 6.29 Bn 6.29 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 775,000.00
Dec 31, 2025 1.42 Mn
Sep 30, 2025 867,000.00
Jun 30, 2025 1.13 Mn
Mar 31, 2025 749,000.00
Dec 31, 2024 879,000.00
Sep 30, 2024 831,000.00
Jun 30, 2024 941,000.00
Mar 31, 2024 914,000.00
Dec 31, 2023 85,000.00
Sep 30, 2023 825,000.00
Jun 30, 2023 141,000.00
Mar 31, 2023 769,000.00
Dec 31, 2022 833,000.00
Sep 30, 2022 731,000.00
Jun 30, 2022 583,000.00
Mar 31, 2022 846,000.00
Dec 31, 2021 460,000.00
Sep 30, 2021 381,000.00
Jun 30, 2021 552,000.00